You can buy Molotinib at the lowest price in the online pharmacy Nextgen.ooo . Momelotinib is a Janus kinase inhibitor used to treat intermediate-to-high-risk myelofibrosis. Momelotinib is an inhibitor of Janus kinase 1 (JAK1) and 2 (JAK2). It is a competitive inhibitor of JAK-ATP binding.
 
First approved by the FDA on September 15, 2023, momelotinib is used to treat myelofibrosis. Myelofibrosis is a group of myeloproliferative neoplasms characterized by abnormal proliferative hematopoietic stem cells, leading to the release of cytokines and growth factors. MF includes primary MF, post-polycythemic MF, and postsessential thrombocythemic MF. Clinical manifestations of MF include anemia and thrombocytosis. Momelotinib blocks the JAK-transducer and activator of transcription (STAT) signaling pathway, which is disrupted in MF.